אלקסן

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

CYTARABINE

MAH:

NOVARTIS ISRAEL LTD

ATC_code:

L01BC01

pharmaceutical_form:

תמיסה להזרקה\אינפוזיה

composition:

CYTARABINE 50 MG / 1 ML

administration_route:

תוך-שדרתי, תת-עורי, תוך-ורידי

prescription_type:

מרשם נדרש

manufactured_by:

EBEWE PHARMA GES.M.B.H NFG. KG, AUSTRIA

therapeutic_group:

CYTARABINE

therapeutic_area:

CYTARABINE

therapeutic_indication:

For induction and maintenance of clinical remission in patients with acute myeloid leukemia, acute non-lymphoblastic leukemias, acute lymphoblastic leukemias, blast crises of chronic myeloid leukemia, diffuse histiocytic lymphomas ( non-Hodgkin's lymphomas of high malignancy).

authorization_date:

2020-11-30